ÐÂÎÅÖÐÐÄ°¢¶û´Äº£Ä¬²¡£¡£¡£¡£¡£¡£¨Alzheimer's Disease, AD£©×÷ΪһÖÖ½¥½øÐÔÉñ¾ÍËÐÐÐÔ¼²²¡£¡£¡£¡£¡£¡£¬£¬ £¬£¬ £¬£¬ÊÇÈ«Çò³Õ´ôÖ¢µÄ×î³£¼ûÔµ¹ÊÔÓÉ£¬£¬ £¬£¬ £¬£¬Ô¤¼Æµ½2050ÄêÈ«Çò»¼ÕßÈËÊý½«µÖ´ï1.52ÒÚ£¬£¬ £¬£¬ £¬£¬³ÉΪÌìÏÂÐÔµÄÖØ´ó¿µ½¡ÌôÕ½¡£¡£¡£¡£¡£¡£ÏÖÔÚÁÙ´²Õï¶Ï½ð±ê×¼¡ª´Å¹²Õñ³ÉÏñ£¨MRI£©ºÍÕýµç×Ó·¢Éä¶Ï²ãɨÃ裨PET£©±£´æ×°±¸Ìڹ󡢿ɼ°ÐÔ²îÇÒÄÑÒÔ¼ì²âÔçÆÚ²¡±äµÈ¾ÖÏÞ¡£¡£¡£¡£¡£¡£Ö»¹ÜÑо¿Åú×¢ÄÔ¼¹ÒººÍѪҺÖеí·ÛÑùÂÑ°×-¦Â£¨A¦Â£©¹Ñ¾ÛÌåˮƽµÄת±äÓëADÏ£ÍûÇ×½üÏà¹Ø£¬£¬ £¬£¬ £¬£¬ÓÈÆäÊÇA¦Â40ºÍA¦Â42±»ÊÓΪҪº¦ÉúÎï±ê¼ÇÎ£¬ £¬£¬ £¬£¬µ«ÏÖÓмì²âÊÖÒÕÈçELISA·¨±£´æѸËÙ¶Èȱ·¦¡¢²Ù×÷·±ËöµÈÎÊÌ⣬£¬ £¬£¬ £¬£¬ÎÞ·¨Öª×ãÔçÆÚÕï¶ÏÐèÇ󡣡£¡£¡£¡£¡£
ÃæÁÙÕâÒ»ÊÖÒÕÌôÕ½£¬£¬ £¬£¬ £¬£¬w88winÓŵÂ(Öйú)ÓÐÏÞ¹«Ë¾µ¥Ï¸°ûÆÊÎöÊÖÒÕÓë×°±¸Ñо¿ÍŶӾÓÉÉîÈëÑо¿£¬£¬ £¬£¬ £¬£¬Àֳɿª·¢³öÒ»ÖÖÐÂÐͳ¬Ö§»¯¹ö»·À©Ôö£¨Hyperbranched Rolling Circle Amplification, HRCA£©Çý¶¯ÊÊÌå´«¸ÐÆ÷£¬£¬ £¬£¬ £¬£¬ÊµÏÖÁ˶ÔA¦Â40ºÍA¦Â42µÄ³¬Ñ¸ËÙ¡¢¶àÖؼì²â¡£¡£¡£¡£¡£¡£¸ÃÊÖÒÕÍ»ÆƹŰå¼ì²âÒªÁìµÄ¾ÖÏÞ£¬£¬ £¬£¬ £¬£¬½«¼ì²âʱ¼äËõ¶ÌÖÁ45·ÖÖÓÄÚ£¬£¬ £¬£¬ £¬£¬Ñ¸Ëٶȵִïpg/mL¼¶±ð£¬£¬ £¬£¬ £¬£¬ÎªADµÄÔçÆÚÕï¶ÏÌṩÁËDZÔÚµÄÓÐÓýâ¾ö¼Æ»®¡£¡£¡£¡£¡£¡£
Ñо¿ÍŶÓÁ¢ÒìÐÔµØÉè¼ÆÁËÓÉʶ±ð×é¼þºÍÐźŷŴó×é¼þ×é³ÉµÄ¼ì²âϵͳ¡£¡£¡£¡£¡£¡£Ê¶±ð×é¼þÓÉÊÊÅäÌ廷״궨̽Õ루Apt-cPLPs£©¸´ºÏÎïÖ§³Ö£¬£¬ £¬£¬ £¬£¬ÐźŷŴó×é¼þÔòÓɳ¬Ö§»¯¹ö»·À©Ôö£¨HRCA£©ÊÖÒÕÇý¶¯¡£¡£¡£¡£¡£¡£
¸Ã´«¸ÐÆ÷µÄÊÂÇéÔÀí°üÀ¨Èý¸öÒªº¦°ì·¨£ºÊ×ÏȽ«ÊÊÅäÌå-»·»¯Ãª¶¨Ì½Õ븴ºÏÎïÐÞÊε½´ÅÖéÍâòÐγÉMAP40»òMAP42¼ì²âµ¥Î»£» £»£»£»£»£»µ±ÑùÆ·Öб£´æÄ¿µÄA¦Âʱ£¬£¬ £¬£¬ £¬£¬Òý·¢¸´ºÏÎï¹¹Ïóת±ä£¬£¬ £¬£¬ £¬£¬µ¼ÖÂcPLPs´Ó¸´ºÏÎïÉϽâÀ룻 £»£»£»£»£»×îºó£¬£¬ £¬£¬ £¬£¬ÊͷŵÄcPLPs×÷Ϊģ°åÆô¶¯HRCA·´Ó¦£¬£¬ £¬£¬ £¬£¬±¬·¢Ö¸Êý¼¶·Å´óµÄÓ«¹âÐźţ¬£¬ £¬£¬ £¬£¬Í¨¹ý¶Ô¹Õµãʱ¼ä£¨Time of Inflection Point, TIP£©µÄÕÉÁ¿ÊµÏÖA¦ÂŨ¶ÈµÄ׼ȷ¶¨Á¿¡£¡£¡£¡£¡£¡£
±¾Ñо¿µÄÒªº¦Á¢ÒìÔÚÓÚͨ¹ý¾«×¼µÄ·Ö×Ó¹¤³ÌÓÅ»¯£¬£¬ £¬£¬ £¬£¬ÏÔÖø½µµÍÁ˼ì²âµÄÅä¾°Ðźš£¡£¡£¡£¡£¡£ÍŶÓÔÚÊÊÅäÌå×îºóÒýÈëÒ»¶Î¹Ñ¾ÛdTÐòÁк󣬣¬ £¬£¬ £¬£¬Apt-cPLPs¸´ºÏÎïµÄÈÜ»¯ÇúÏß±¬·¢ÏÔÖøת±ä£¬£¬ £¬£¬ £¬£¬ÔÓ·å½µµÍ£¬£¬ £¬£¬ £¬£¬Ö÷·åÔöÇ¿£¬£¬ £¬£¬ £¬£¬Åú×¢ÆäÈÈÎȹÌÐԺͽṹ¾ùÒ»ÐÔ»ñµÃÏÔÖøÔöÇ¿¡£¡£¡£¡£¡£¡£
ΪÉîÈëÃ÷È·ÕâÒ»Õ÷Ï󣬣¬ £¬£¬ £¬£¬ÍŶӽÓÄÉ·Ö×Ó¶¯Á¦Ñ§£¨Molecular Dynamics, MD£©Ä£ÄâÊÖÒÕ´Ó×ÔÓÉÄܽǶÈÕ¹ÏÖÁËÆäÄÚÔÚ»úÖÆ¡£¡£¡£¡£¡£¡£Ä£ÄâЧ¹ûÅú×¢£¬£¬ £¬£¬ £¬£¬ÊÊÅäÌåÑÓÉìºóÌṩÁËÌØÁíÍâÍŽá×ÔÓÉÄÜ£¬£¬ £¬£¬ £¬£¬Ê¹A2P42¸´ºÏÎïµÄÍŽá×ÔÓɵִï-190.95 kcal/mol£¬£¬ £¬£¬ £¬£¬ÏÔÖø¸ßÓÚδÑÓÉ츴ºÏÎïµÄ-173.167 kcal/mol£¬£¬ £¬£¬ £¬£¬ÕâÖ÷Òª¹éÒòÓÚ·¶µÂ»ªÁ¦ºÍ¼«ÐÔÈܼÁ»¯ÄÜÁ¿µÄÔöÌí¡£¡£¡£¡£¡£¡£
ÐÔÄܲâÊÔÅú×¢£¬£¬ £¬£¬ £¬£¬¸Ã´«¸ÐÆ÷Õ¹ÏÖ³ö׿ԽµÄÆÊÎöÐÔÄÜ¡£¡£¡£¡£¡£¡£¶ÔA¦Â40ºÍA¦Â42µÄ¼ì²âÏÞ»®·ÖµÍÖÁ2.48 pg/mLºÍ0.27 pg/mL£¬£¬ £¬£¬ £¬£¬ÏßÐÔ¹æÄ£¿í´ï4¸öÊýÄ¿¼¶¡£¡£¡£¡£¡£¡£ÓÈΪÖ÷ÒªµÄÊÇ£¬£¬ £¬£¬ £¬£¬¸Ãƽ̨֧³ÖÔÚ¼òµ¥·´Ó¦ÏµÍ³ÖÐͬʱ¡¢»¥²»×ÌÈŵؼì²âA¦Â40ºÍA¦Â42£¬£¬ £¬£¬ £¬£¬ÕÃÏÔÁËÆä¸ßЧµÄ¶àÖؼì²âÄÜÁ¦¡£¡£¡£¡£¡£¡£´«¸ÐÆ÷ÔÚÃæÁÙÖØ´óÉúÎï»ùÖÊ£¨ÈçÈ˹¤ÄÔ¼¹ÒººÍÏ¡ÊÍѪÇ壩ʱ£¬£¬ £¬£¬ £¬£¬ÒÀÈ»¼á³ÖÁ˸ßÌØÒìÐÔºÍ׼ȷµÄ½ÓÄÉÂÊ£¨92.32%-112.87%£©£¬£¬ £¬£¬ £¬£¬Ö¤ÊµÎúÆäÓÅÒìµÄÁÙ´²ÊÊÓÃÔ¶¾°¡£¡£¡£¡£¡£¡£
¸ÃÑо¿Àֳɿª·¢ÁËÒ»ÖÖ»ùÓÚºãÎÂÀ©ÔöµÄ³¬Ñ¸ËÙ¼ì²âƽ̨£¬£¬ £¬£¬ £¬£¬ÈÚºÏÁËÊÊÅäÌåµÄ¸ßÌØÒìÐÔÓ볬֧»¯¹ö»·À©ÔöµÄÇ¿Ê¢ÐźŷŴóÄÜÁ¦£¬£¬ £¬£¬ £¬£¬ÊµÏÖÁ˶԰¢¶û´Äº£Ä¬²¡Òªº¦ÉúÎï±ê¼ÇÎïµÄ¾«×¼ÕÉÁ¿¡£¡£¡£¡£¡£¡£¸ÃÒªÁì¾ßÓÐѸËٶȸߡ¢ÌØÒìÐÔÇ¿¡¢¼ì²â¿ìËÙ£¨<45·ÖÖÓ£©¡¢±¾Ç®µÍµÈÓÅÊÆ£¬£¬ £¬£¬ £¬£¬ÎªADµÄÔçÆÚÎÞ´´Õï¶ÏºÍ²¡³Ì¼à²âÌṩÁËÇ¿ÓÐÁ¦µÄÊÖÒÕ¹¤¾ß¡£¡£¡£¡£¡£¡£¸ÃÊÂÇéÒÔ¡°Novel Hyperbranched Rolling Circle Amplification-Driven Aptasensor for Ultrasensitive Multiplexed Detection of Alzheimer's Disease Biomarkers¡±ÎªÌâ½ÒÏþÓÚ»¯Ñ§´«¸ÐÆ÷ÁìÓòȨÍþÆÚ¿¯¡¶Sensors and Actuators: B. Chemical¡·£¨DOI:10.1016/j.snb.2025.137816£¬£¬ £¬£¬ £¬£¬IF=7.7£¬£¬ £¬£¬ £¬£¬ÖпÆÔº1Çø£©£¬£¬ £¬£¬ £¬£¬w88winÓŵÂ(Öйú)ÓÐÏÞ¹«Ë¾ÎªµÚÒ»µ¥Î»£¬£¬ £¬£¬ £¬£¬ÖӼο¡ÖúÀíÑо¿Ô±¡¢ÍõÆôΰ²©Ê¿»®·ÖΪÂÛÎĵÚÒ»¡¢µÚ¶þ×÷Õߣ¬£¬ £¬£¬ £¬£¬ÏàÖúµ¥Î»Öйú¿ÆѧԺËÕÖÝÒ½¹¤Ëù¹ËÍ©Ðñ¸±Ñо¿Ô±ºÍ°×ÅôÀûÑо¿Ô±ÎªÅäºÏͨѶ×÷Õß¡£¡£¡£¡£¡£¡£Ñо¿ÊÂÇé»ñµÃÁ˹㶫ʡ»ù´¡ÓëÓ¦Óûù´¡Ñо¿»ù½ð£¨2022A1515110074£©¡¢¹ã¶«Ê¡ÖصãÁìÓòÑз¢ÍýÏ루2022B0303020001£©ºÍ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¨52102099£©µÄ×ÊÖú¡£¡£¡£¡£¡£¡£